The Biggest Threat to Medical Device Revenue Growth During the Pandemic

A financial analyst speculated on how the coronavirus pandemic could impact growth for medical device companies.

阅读更多

4 Trends and Expectations for Drug Delivery in 2020

The new year will bring more opportunities for drug and device companies to work together to support patient-centric therapies.

阅读更多

SweynTooth Cybersecurity Vulnerabilities Put Dozens of Medical Devices at Risk

FDA warned patients, providers, and manufacturers about the Bluetooth-related cybersecurity vulnerabilities – collectively dubbed SweynTooth – that may introduce risks for certain medical devices.

Exploring the Latest in Sensor Technologies for Medtech

An expert talks about the latest in sensor technology development and shares a few tips on how medical device developers can find the right technology to suit their device.

阅读更多

Can These Pediatric Devices Make a Difference?

Check out the 12 finalists in the “Make Your Medical Device Pitch for Kids!” competition to be held live during the 7th Annual Pediatric Device Innovation Symposium hosted by Children’s National Health System.

3 Critical Considerations for Evaluating Off-the-Shelf Software for Medical Devices

Manufacturers would be wise to understand the impact of these three risk factors when choosing software partners for their medical device.

Listening to Data’s Story for Impactful Medical Device Development

An industry expert asks ‘what story is data telling you about infusion pumps and other devices?’

In Vivo Sensors: More than a Space-Age Fantasy?

It’s easy to envision the roles implantable sensors could perform. But is it too hard to overcome the risks?

Fitbit Deal Helps Google Go Wrist-to-Wrist with Apple in Healthcare

Google could get a significant foothold in the wearables market through its $2.1 billion acquisition of Fitbit. The Apple Watch and Fitbit have been taking deeper dives into healthcare over the past few years.

阅读更多

New Expanded Indication Could Change the TAVR Narrative

Now Edwards and Medtronic’s transcatheter aortic valve replacement devices can be used in patients with low-risk for death or major complications associated with open-heart surgery. One analyst said the conversation will eventually shift toward TAVR being the “preferred treatment method.”